Luteoskyrin

Luteoskyrin
Names
IUPAC name
5,8,10,14,20,23,25,28-octahydroxy-6,21-dimethyloctacyclo[14.11.1.02,11.02,15.04,9.013,17.017,26.019,24]octacosa-4,6,8,10,19,21,23,25-octaene-3,12,18,27-tetrone
Other names
  • (1.beta.,1.beta.,3.beta.,3.beta.)-8,8-dihydroxy-rugulosin
  • 2,2,4,4,5,5,8,8-octahydroxy-2,2,3,3-tetrahydro-7,7-dimethyl-1,1-bianthraquinone
  • 8,8-dihydroxy-rugulosin
  • 2,2,3,3-tetrahydro-2,2,4,4,5,5,8,8-octahydroxy-7,7-dimethyl-(1,1-bianthracene)-9,9,10,10-tetrone
  • flavomycelin[1]
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
EC Number
  • 244-631-1
KEGG
UNII
  • InChI=1S/C30H22O12/c1-5-3-7(31)9-11(19(5)33)27(41)29-13-14-24(38)17(29)26(40)16-22(36)10-8(32)4-6(2)20(34)12(10)28(42)30(14,16)18(23(13)37)25(39)15(29)21(9)35/h3-4,13-14,17-18,23-24,31-38H,1-2H3
  • Key: FAZDYVMEXQHRLI-UHFFFAOYSA-N
  • natural: InChI=1S/C30H22O12/c1-5-3-7(31)9-11(19(5)33)27(41)29-13-14-24(38)17(29)26(40)16-22(36)10-8(32)4-6(2)20(34)12(10)28(42)30(14,16)18(23(13)37)25(39)15(29)21(9)35/h3-4,13-14,17-18,23-24,31-34,37-40H,1-2H3/t13-,14-,17+,18+,23-,24-,29+,30+/m1/s1
    Key: KXNUPFFSGSRABD-TZRHFUAUSA-N
  • Cc1cc(c2c(c1O)C(=O)C34C5C6C(C3C(=O)C7=C(c8c(cc(c(c8C(=O)C67C(C5O)C(=O)C4=C2O)O)C)O)O)O)O
  • natural: Cc1cc(c2c(c1O)C(=O)[C@]34[C@@H]5[C@@H]6[C@H]([C@H]3C(=C7[C@@]6([C@@H]([C@@H]5O)C(=C4C2=O)O)C(=O)c8c(c(cc(c8O)C)O)C7=O)O)O)O
Properties
C30H22O12
Molar mass 574.494 g·mol−1
Appearance Yellow rectangular crystals
Density 2.03 g/cm3
Melting point 287 °C (549 °F; 560 K)
Boiling point 979.7–1,118.1 °C (1,795.5–2,044.6 °F; 1,252.8–1,391.2 K)
Hazards
Occupational safety and health (OHS/OSH):
Main hazards
Toxic to aquatic life with long-lasting effects, harmful if swallowed.
GHS labelling:[2]
H302, H410
P264, P270, P273, P301+P312, P330, P391, P501
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Luteoskyrin is a carcinogenic mycotoxin with the molecular formula C30H22O12 which is produced by the mold Penicillium islandicum.[3][4][5][6] Luteoskyrin has strong cytotoxic effects.[7][8] Luteoskyrin can cause the yellow rice disease.[3]

History

The mold Talaromyces (Penicillium) islandicus was discovered in the Japanese South Sea Islands after World War II. At that time, the country was facing a crisis and relied on imported food from countries such as Egypt. Around the 1950s, the Japanese government started health inspections and realized that some of the rice was yellow. Fungal isolation experiments were performed from which T. islandicus was identified as a key agent. Further experiments lead to the discovery of a yellow, crystalline pigment which they named luteoskyrin. Mold contaminated rice was then discovered to produce liver cirrhosis and liver tumours in rats, a condition named "Yellow Rice Syndrome".[6][9][10]

Biosynthesis

(–)-luteoskyrin can be synthesized by first isolating catenarin from Penicillium islandicum NRLL 1036. Catenarin is then reduced to 3,5,8,9,10-pentahydroxy-6-methyl-3,4-dihydroanthracen-1(2H)-one via a chemoenzymatic sequence catalyzed by NADPH-dependent anthrol reductase (ARti). Further oxidation yields a key intermediate, (R)-dihydrocatenarin, which undergoes further non-enzymatic autooxidation under aerobic conditions and generates radical species. Those couple via C−C bond formation to produce a dimeric intermediate which eventually cyclizes into (–)-rubroskyrin via C−C bond formation coupling reactions. (–)-rubroskyrin finally converts to (–)-luteoskyrin via a base-catalyzed Michael addition.[11]

Chemical And Physical Properties

Reactivity 

Luteoskyrin is poorly soluble in most organic compounds and mildly alkaline conditions. In more alkaline environment (pH>12) however, it is almost fully deprotonated and subsequently very soluble.[12]

Solubility

Under strongly basic conditions luteoskyrin is very unstable. It exhibits great susceptibility to light and chemical degradation. Highly concentrated solutions in DMSO lead to decomposition even in the absence of light, at room temperature. The compound is particularly photosensitive in acetone.[12]

Detection Methods

Conventionally, luteoskyrin can be determined via thin-layer chromatography with Silica gel G in an isopropanol/ammonium hydroxide mixture, but not with great sensitivity and extensive detection limits.[12] Alternatively, liquid chromatography-tandem mass spectrometry (LC-MS-MS) with electrospray ionization has been shown to provide highly sensitive results with minor clean-up required.[10]

Availability, Use And Exposure

Availability

Luteoskyrin occurs in food. It is known to be a storage mold contaminant of rice or cereals that appears under high humidity conditions.[6]

Use

This compound is currently being used as a tool in scientific research, specially to study liver toxicity, and to investigate antibacterial and antifungal activity and perform mycotoxin analyses.[13][14][15]

Exposure

The main exposure route is via oral ingestion, however in research settings luteoskyrin has been supplied through subcutaneous injection, intravenous injection, and oral administration.[13][16]

ADME

Absorption

Luteoskyrin is a lipophilic bis-anthraquinone that, if ingested, is absorbed through the gastrointestinal tract via passive diffusion. It travels via the portal vein directly into the liver.[16]

Distribution

It highly accumulated at the mitochondria and endoplasmic reticulum of liver cells (max accumulation within a day) and minor distribution to the serum and kidneys.[16][17] Studies have reported accumulation after several days after exposure and sex differences in the half-life of this compound.[13][17]

Metabolism

It undergoes hepatic biotransformation, where it is reduced to semiquinone radicals by NADPH-dependent cytochrome reductases.[18]

Excretion

The main routes of excretion are biliary and fecal. Small amounts are processed by the liver and excreted through bile into feces, while a minor fraction is processed by kidneys and excreted in urine.[16] However, the clearance rate is low due to protein/DNA binding, which prolongs exposure and leads to chronic liver injury.[17]

Molecular Mechanism of Action

Luteoskyrin accumulates selectively in the liver. The liver contains high levels of mitochondria and cytochrome p450 reductase, driving redox cycling. Its main toxicity mechanism involves redox cycling and ROS generation. Redox cycling is stimulated by the many quinone groups in luteoskyrin. When luteoskyrin is reduced, it can react with oxygen because the quinone groups will undergo one-electron redox cycling. The reactive oxygen species that are being formed result in hydroxyl radicals (•OH). The production of oxidative species such as superoxide and hydroxyl radicals is a major driver for oxidative stress.[19]

Hydroxyl radicals initiate an induction of lipid peroxidation of fatty acids in cell membranes. The radical takes a hydrogen atom from a membrane lipid (LH). A lipid radical (L•) is now formed, which will react with oxygen to a lipid peroxyl radical (LOO•). This lipid peroxyl radical is then able to attack new membrane lipids, leading to a loss of membrane integrity and leakage of transaminases. Also, by damaging mitochondrial membranes, ROS is even further stimulated, because of electron leakage. However, ROS can also attack guanine in the DNA, where it mismatches with adenine leading to guanine to a thymine transversion. A change in toxicity is indicated by an increase in 8-hydroxy-deoxyguanosine (8-OHdG), a marker for hydroxy radical mediated modification of DNA guanine residues.[17] It thus indicates that the hydroxy radicals are attacking DNA and oxidatively damaging it. ROS-mediated oxidative DNA damage contributes to mutagenicity and carcinogenicity.

Furthermore, because luteoskyrin is an aromatic, planar molecule, it can intercalate into DNA where it is able to bind to cellular macromolecules such as proteins and nucleic acids. By binding these macromolecules, luteoskyrin inhibits DNA/RNA synthesis, contributing to genotoxicity.[17]

Toxicology Data

Luteoskyrin has been found to be hepatoxic; itcauses oxidative stress, cellular damage and necrosis, impaired mitochondrial function and liver injury. The lethal toxicity is higher in male mice compared to female mice, since luteoskyrin accumulates in the liver at a much higher rate in males.[17]

Luteoskyrin is also able to modify DNA and therefore classified as a group 3 carcinogen in mice by the IARC.[18]

Risk Management And Regulations

No regulations or definite limits have been set in any country to govern all important mycotoxins in foods, including luteoskyrin.[20] It has been reported that certain phenolic antioxidants with antifungal properties suppress the growth of P. islandicum and consequently the production of luteoskyrin in rice. However, effective concentrations could exceed the legal limit, and the antioxidant activity relies on food composition. Further research is needed to validate the efficacy of those compounds in the food preservation industry.[21]

References

  1. ^ "Luteoskyrin – Substance Record". Global Substance Registration System (GSRS). National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. Retrieved 12 March 2026.
  2. ^ "Safety Data Sheet: (−)-Luteoskyrin". DC Chemicals. DC Chemicals. Retrieved 12 March 2026.
  3. ^ a b Weidenbörner, Martin (7 March 2013). Lexikon der Lebensmittelmykologie (in German). Springer-Verlag. p. 82. ISBN 978-3-642-57058-2.
  4. ^ Hänsel, Rudolf; Keller, Konstantin; Rimpler, Horst; Schneider, Georg (8 March 2013). Hagers Handbuch der Pharmazeutischen Praxis: Drogen P-Z Folgeband 2 (in German). Springer-Verlag. ISBN 978-3-642-57881-6.
  5. ^ Eisenbrand, Gerhard; Schreier, Peter (28 May 2014). RÖMPP Lexikon Lebensmittelchemie, 2. Auflage, 2006 (in German). Georg Thieme Verlag. p. 41. ISBN 978-3-13-179532-8.
  6. ^ a b c Ueno, Yoshio; Ishikawa, Ichijiro (September 1969). "Production of Luteoskyrin, a Hepatotoxic Pigment, by Penicillium islandicum Sopp". Applied Microbiology. 18 (3): 406–409. doi:10.1128/AM.18.3.406-409.1969. ISSN 0003-6919. PMC 377994. PMID 5373676.
  7. ^ Keutel, J.; Möckel, H. (1 December 1969). "Induction of chromosomal breakage in cultured human leucocytes by luteoskyrin". Humangenetik. 7 (4): 344–348. doi:10.1007/BF00283556. ISSN 1432-1203. PMID 5365575. S2CID 7401409.
  8. ^ Möckel, Horst. Chromosomenaberrationen an kultivierten menschlichen leukozyten (in German). Marburg. p. 39.
  9. ^ Schafhauser, Thomas; Wibberg, Daniel; Rückert, Christian; Winkler, Anika; Flor, Liane; van Pée, Karl-Heinz; Fewer, David P.; Sivonen, Kaarina; Jahn, Linda; Ludwig-Müller, Jutta; Caradec, Thibault; Jacques, Philippe; Huijbers, Mieke M. E.; van Berkel, Willem J. H.; Weber, Tilmann (2015-10-10). "Draft genome sequence of Talaromyces islandicus ("Penicillium islandicum") WF-38-12, a neglected mold with significant biotechnological potential". Journal of Biotechnology. 211: 101–102. doi:10.1016/j.jbiotec.2015.07.004. ISSN 0168-1656.
  10. ^ a b Mizutani, Kohei; Kumagai, Susumu; Mochizuki, Naoki; Kitagawa, Yasushi; Sugita-Konishi, Yoshiko (2009-06-01). "Determination of a Yellow Rice Toxin, Luteoskyrin, in Rice by Using Liquid Chromatography–Tandem Mass Spectrometry with Electrospray Ionization". Journal of Food Protection. 72 (6): 1321–1326. doi:10.4315/0362-028X-72.6.1321. ISSN 0362-028X.
  11. ^ Mondal, Amit; Saha, Nirmal; Husain, Syed Masood (August 2022). "Concise chemoenzymatic total synthesis of (−)-rubroskyrin, (−)-deoxyrubroskyrin (−)-luteoskyrin, and (−)-deoxyluteoskyrin". Tetrahedron Chem. 3 100030. doi:10.1016/j.tchem.2022.100030. ISSN 2666-951X.
  12. ^ a b c Bouhet, Jean C.; Pham Van Chuong, Paul; Toma, Flavio; Kirszenbaum, Marek; Fromageot, Pierre (May 1976). "Isolation and characterization of luteoskyrin and rugulosin, two hepatotoxic anthraquinonoids from Penicillium islandicum Sopp. and Penicillium rugulosum Thom". Journal of Agricultural and Food Chemistry. 24 (5): 964–972. doi:10.1021/jf60207a028. ISSN 0021-8561.
  13. ^ a b c Ueno, Ikuko; Hayashi, Tomiko; Ueno, Yoshio (1974-01-01). "Pharmacokinetic Studies on the Hepatotoxicity of Luteoskyrin. (1) Intracellular Distribution of Radioactivity in the Liver of Mice Administered 3H-Luteoskyrin". Japanese Journal of Pharmacology. 24 (4): 535–542. doi:10.1254/jjp.24.535. ISSN 0021-5198.
  14. ^ Sadorn, Karoon; Saepua, Siriporn; Boonyuen, Nattawut; Komwijit, Somjit; Rachtawee, Pranee; Pittayakhajonwut, Pattama (2019-06-21). "Phenolic glucosides and chromane analogs from the insect fungus Conoideocrella krungchingensis BCC53666". Tetrahedron. 75 (25): 3463–3471. doi:10.1016/j.tet.2019.05.007. ISSN 0040-4020.
  15. ^ Goessens, T.; Mouchtaris-Michailidis, T.; Tesfamariam, K.; Truong, N. N.; Vertriest, F.; Bader, Y.; De Saeger, S.; Lachat, C.; De Boevre, M. (2024-02-01). "Dietary mycotoxin exposure and human health risks: A protocol for a systematic review". Environment International. 184 108456. doi:10.1016/j.envint.2024.108456. ISSN 0160-4120. PMC 10895515. PMID 38277998.
  16. ^ a b c d Uraguchi, Kenji; Ueno, Ikuko; Ueno, Yoshio; Komai, Yoshitomo (1972-03-01). "Absorption, distribution and excretion of luteoskyrin with special reference to the selective action on the liver". Toxicology and Applied Pharmacology. 21 (3): 335–347. doi:10.1016/0041-008X(72)90153-6. ISSN 0041-008X.
  17. ^ a b c d e f Tatsuki, Masuda; Junko, Ito; Shinobu, Akuzawa; Kaori, Ishii; Hidetoshi, Takagi; Yoshio, Ueno (June 1992). "Hepatic accumulation and hepatotoxicity of luteoskyrin in mice". Toxicology Letters. 61 (1): 9–20. doi:10.1016/0378-4274(92)90058-R.
  18. ^ a b PubChem. "Rugulosin, 8,8'-dihydroxy-, (1S,1'S,2R,2'R,3S,3'S,9aR,9'aR)-". pubchem.ncbi.nlm.nih.gov. Retrieved 2026-03-12.
  19. ^ Halaris, A. E.; Belendiuk, K. T.; Freedman, D. X. (1975-10-15). "Antidepressant drugs affect dopamine uptake". Biochemical Pharmacology. 24 (20): 1896–1897. doi:10.1016/0006-2952(75)90412-8. ISSN 0006-2952. PMID 19.
  20. ^ Barthel, W.; Markwardt, F. (1975-10-15). "Aggregation of blood platelets by adrenaline and its uptake". Biochemical Pharmacology. 24 (20): 1903–1904. doi:10.1016/0006-2952(75)90415-3. ISSN 0006-2952. PMID 20.
  21. ^ Tseng, Hshinn-Hshiung; Tseng, Tsung-Che (1995-02-01). "Effects of butylated hydroxyanisole, butylated hydroxytoluene and tertiary butylhydroquinone on growth and luteoskyrin production byPenicillium islandicum". Mycopathologia. 129 (2): 73–78. doi:10.1007/BF01103463. ISSN 1573-0832.

Further reading